|Articles|November 2, 2003
- Pharmaceutical Technology-11-02-2003
- Volume 27
- Issue 11
FDA Seeks Risk-Based Inspection Program
Author(s)Jill Wechsler
FDA's new policies intend to make GMP inspections more efficient and apply to stricter rules to high-risk products and processes.
Advertisement
Articles in this issue
over 22 years ago
FDA Will Drive Changes for Contract Businessover 22 years ago
In the Spotlight--Decemberover 22 years ago
Novemember 2003over 22 years ago
Routine Sample Size for a Retest Procedureover 22 years ago
November 2003over 22 years ago
Clearing Regulatory Hurdlesover 22 years ago
Improving Protein Capture for Transgenic Drug ProcessingNewsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Women in STEM: Early Phase Drug Development
2
Drug Digest: Outsourcing Partnerships Fuel Global Biopharma Discovery and Scale-Up
3
FDA Grants Priority Review For Pfizer’s Marstacimab for Hemophilia A or B
4
PharmTech Weekly Roundup - February 6, 2026
5